Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
The longitudinal cost of end-stage renal disease in persons with diabetes in the United States
Diane L. Manninen
, Frederick B. Dong
, Erik J. Dasbach
, George W. Carides
, William H. Herman
, Allan J. Collins
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The longitudinal cost of end-stage renal disease in persons with diabetes in the United States'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
United States
100%
End-stage Renal Disease
100%
Patients with Diabetes
100%
Medicare Reimbursement
100%
Dialysis Initiation
100%
Health Care Costs
50%
Dialysis
25%
United States Renal Data System (USRDS)
25%
First Month
25%
Direct Medical Costs
25%
Cost Increase
25%
Fold Increase
25%
Payment for Services
25%
Medicine and Dentistry
Health Care Cost
100%
Medicare
100%
Diabetes
100%
End Stage Renal Disease
100%
Patient with Diabetes
25%
Nursing and Health Professions
Medicare
100%
End Stage Renal Disease
100%
Health Care Cost
50%
Patient with Diabetes
25%
Health Economics
25%